DM firm expands its West Coast office

Share this article:
Direct marketing solutions firm Structural Graphics has increased the size of its West Coast offices and added new personnel under a recent expansion.

In July, the firm moved from offices in Santa Monica, CA to larger digs in nearby Culver City.
“The old space didn't suit us any more,” said Michael Dambra VP, marketing Structural Graphics. “The new office is a larger space where we will be able to do more for our West Coast clients, independently from our headquarters in Essex, CT.”

Dambra said the firm has also added advertising and marketing veterans Bill May and Susanne Andrey to enhance its West Coast operations.

May joins as project manager from Dailey and Associates Advertising in West Hollywood, CA, where he worked for 17 years, most recently as VP and director of graphic services.

Andrey joins as account manager and was previously US sales and marketing manager for Button Group. There she worked closely with outside designers and printers to develop marketing materials for meeting planners, tourism boards and consumer product lines.

Structural Graphics also added Trusha Bhatt from Publicis to serve as internal sales partner, Dambra said.

According to Dambra, business has picked up for Structural Graphics in recent months, a result of doctors becoming less available to spend time with pharma sales reps.

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...